Literature DB >> 32436025

Treatment of Oculoplastic and Ocular Surface Disease in Eyes Implanted with a Type I Boston Keratoprosthesis in Southern China: A Retrospective Study.

Yuying Zhang1, Zhancong Ou1, Jin Zhou1, Jiajie Zhai2, Jianjun Gu3,4, Jiaqi Chen1,2.   

Abstract

INTRODUCTION: This study aimed to describe the clinical features, surgical management of the eyelid and ocular surface, and outcomes of 16 patients implanted with a Boston type I keratoprosthesis (KPro).
METHODS: A retrospective, single-center, consecutive case series of 16 patients with Stevens-Johnson syndrome (1), ocular chemical burns (12), and ocular thermal burns (3) implanted with KPro was studied. All subjects were men aged 27-51 years. Surgical treatment and outcomes for eyelid malposition, symblepharon, and glaucoma were assessed.
RESULTS: From September 2010 to February 2019, 29 patients were admitted to Zhongshan Ophthalmic Center for KPro implantation, of whom 16 (55%) required eyelid or ocular surface surgeries to maintain hydration and protect the corneal tissue, which is vulnerable to epithelial defects. Forty-one adnexal surgical procedures were performed. The most common indication for surgery was symblepharon, and the most frequent procedures were symblepharon lysis with ocular mucous membrane grafts and amniotic membranes (7) and full-thickness skin grafts to the eyelids (7). Preoperative conjunctival injection and corneal staining were documented in 9 (56%) and 8 (50%) eyes, respectively, and at up to 4 months postoperative follow-up (the last adnexal surgery before KPro) were recorded in 3 (19%, p = 0.03) and 2 (12%, p = 0.02) eyes, respectively. Glaucoma drainage devices were inserted in six patients. One patient with Stevens-Johnson syndrome underwent FP7 Ahmed glaucoma valve (AGV) implantation inferotemporally and developed plate exposure 2 months postoperatively. Five patients underwent FP8 AGV implantation with tube insertion into the vitreous cavity due to the scarred conjunctiva and limited subconjunctival space. In the study period, intraocular pressure (IOP) was in the normal range, and no tube or plate exposure was observed.
CONCLUSION: The ocular environment is critical for successful KPro surgery. A multidisciplinary approach for any lid and ocular surface abnormality in ocular burns or Stevens-Johnson syndrome is important to improve the quality of the ocular surface and accommodate KPro and AGV, which is vital for maintaining vision after KPro surgery. FP8 AGV may be feasible for IOP control in adult KPro cases with restricted subconjunctival space.

Entities:  

Keywords:  Acellular dermis; Ahmed glaucoma valve; Boston keratoprosthesis; Glaucoma; Ocular burns; Ocular surface; Oculoplastic surgery; Pars plana vitrectomy

Year:  2020        PMID: 32436025     DOI: 10.1007/s12325-020-01381-3

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  32 in total

1.  Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis.

Authors:  Fabiano Cade; Cynthia L Grosskreutz; Allyson Tauber; Claes H Dohlman
Journal:  Cornea       Date:  2011-12       Impact factor: 2.651

2.  The use of acellular human dermis composite graft for upper eyelid reconstruction in ocular injury.

Authors:  Jianjun Gu; Jiaje Zhai; Jiaqi Chen
Journal:  J Trauma Acute Care Surg       Date:  2012-01       Impact factor: 3.313

3.  Management of cicatricial entropion of the upper lid using acellular human dermal allograft.

Authors:  J Chen; Z Wang; J Gu
Journal:  J Plast Reconstr Aesthet Surg       Date:  2007-07-25       Impact factor: 2.740

4.  Boston Type 2 keratoprosthesis- mid term outcomes from a tertiary eye care centre in India.

Authors:  Geetha Iyer; Bhaskar Srinivasan; Shweta Agarwal; Ramya Ravindran; Ekta Rishi; Pukhraj Rishi; Sripriya Krishnamoorthy
Journal:  Ocul Surf       Date:  2018-08-26       Impact factor: 5.033

5.  Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.

Authors:  Ramon Lee; Ziad Khoueir; Edem Tsikata; James Chodosh; Claes H Dohlman; Teresa C Chen
Journal:  Ophthalmology       Date:  2016-08-15       Impact factor: 12.079

6.  Design and Outcomes of a Novel Keratoprosthesis: Addressing Unmet Needs in End-Stage Cicatricial Corneal Blindness.

Authors:  Shaunak K Bakshi; John Graney; Eleftherios I Paschalis; Shweta Agarwal; Sayan Basu; Geetha Iyer; Christopher Liu; Bhaskar Srinivasan; James Chodosh
Journal:  Cornea       Date:  2020-04       Impact factor: 2.651

Review 7.  A Novel Technique for Amniotic Membrane Transplantation in Patients with Acute Stevens-Johnson Syndrome.

Authors:  Kelly N Ma; Aristomenis Thanos; James Chodosh; Ankoor S Shah; Iason S Mantagos
Journal:  Ocul Surf       Date:  2015-09-24       Impact factor: 5.033

8.  Boston keratoprosthesis type 1 for herpes simplex and herpes zoster keratopathy.

Authors:  Curtis R Brown; Michael D Wagoner; Jeffrey D Welder; Alex W Cohen; Kenneth M Goins; Mark A Greiner; Anna S Kitzmann
Journal:  Cornea       Date:  2014-08       Impact factor: 2.651

9.  Surgical strategies for fornix reconstruction based on symblepharon severity.

Authors:  Ahmad Kheirkhah; Gabriela Blanco; Victoria Casas; Yasutaka Hayashida; Vadrevu K Raju; Scheffer C G Tseng
Journal:  Am J Ophthalmol       Date:  2008-06-02       Impact factor: 5.258

Review 10.  Keratoprosthesis: Current global scenario and a broad Indian perspective.

Authors:  Geetha Iyer; Bhaskar Srinivasan; Shweta Agarwal; Deepti Talele; Ekta Rishi; Pukhraj Rishi; Sripriya Krishnamurthy; Lingam Vijaya; Nirmala Subramanian; Shanmugasundaram Somasundaram
Journal:  Indian J Ophthalmol       Date:  2018-05       Impact factor: 1.848

View more
  1 in total

Review 1.  Surgical Strategies for Eyelid Defect Reconstruction: A Review on Principles and Techniques.

Authors:  Yuxin Yan; Rao Fu; Qiumei Ji; Chuanqi Liu; Jing Yang; Xiya Yin; Carlo M Oranges; Qingfeng Li; Ru-Lin Huang
Journal:  Ophthalmol Ther       Date:  2022-06-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.